Xizhong Cui

Publications

• Confirmed Bacillus Anthracis Infection Among Persons Who Inject Drugs, Scotland, 2009-2010
  Emerging Infectious Diseases. Sep, 2014  |   Pubmed ID: 25148307
• Tidal Volume and Plateau Pressure Use for Acute Lung Injury from 2000 to Present: a Systematic Literature Review
  Critical Care Medicine. Oct, 2014  |   Pubmed ID: 25098333
• Purified Cell Wall from the Probiotic Bacterium Lactobacillus Gasseri Activates Systemic Inflammation And, at Higher Doses, Produces Lethality in a Rat Model
  Critical Care (London, England). 2014  |   Pubmed ID: 24989885
• B. Anthracis Associated Cardiovascular Dysfunction and Shock: the Potential Contribution of Both Non-toxin and Toxin Components
  BMC Medicine. 2013  |   Pubmed ID: 24107194
• The Surviving Sepsis Campaign's Revised Sepsis Bundles
  Current Infectious Disease Reports. Oct, 2013  |   Pubmed ID: 23990342
• Antitumor Necrosis Factor Therapy is Associated with Improved Survival in Clinical Sepsis Trials: a Meta-analysis
  Critical Care Medicine. Oct, 2013  |   Pubmed ID: 23887234
• Bacillus Anthracis Cell Wall Peptidoglycan but Not Lethal or Edema Toxins Produces Changes Consistent with Disseminated Intravascular Coagulation in a Rat Model
  The Journal of Infectious Diseases. Sep, 2013  |   Pubmed ID: 23737601
• B. Anthracis Edema Toxin Increases CAMP Levels and Inhibits Phenylephrine-stimulated Contraction in a Rat Aortic Ring Model
  American Journal of Physiology. Heart and Circulatory Physiology. Jul, 2013  |   Pubmed ID: 23585140
• An Overview of Anthrax Infection Including the Recently Identified Form of Disease in Injection Drug Users
  Intensive Care Medicine. Jul, 2012  |   Pubmed ID: 22527064
• Protective Antigen Antibody Augments Hemodynamic Support in Anthrax Lethal Toxin Shock in Canines
  The Journal of Infectious Diseases. Mar, 2012  |   Pubmed ID: 22223857
• The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock
  Toxins. Sep, 2011  |   Pubmed ID: 22069762
• The Evolving Experience with Therapeutic TNF Inhibition in Sepsis: Considering the Potential Influence of Risk of Death
  Expert Opinion on Investigational Drugs. Nov, 2011  |   Pubmed ID: 21961576
• The Individual Survival Benefits of Tumor Necrosis Factor Soluble Receptor and Fluid Administration Are Not Additive in a Rat Sepsis Model
  Intensive Care Medicine. Oct, 2011  |   Pubmed ID: 21922303
• Anthrax Infection
  American Journal of Respiratory and Critical Care Medicine. Dec, 2011  |   Pubmed ID: 21852539
• Disruption of the Transient Receptor Potential Vanilloid 1 Can Affect Survival, Bacterial Clearance, and Cytokine Gene Expression During Murine Sepsis
  Anesthesiology. May, 2011  |   Pubmed ID: 21383614
• Delayed Treatment with W1-mAb, a Chimpanzee-derived Monoclonal Antibody Against Protective Antigen, Reduces Mortality from Challenges with Anthrax Edema or Lethal Toxin in Rats and with Anthrax Spores in Mice
  Critical Care Medicine. Jun, 2011  |   Pubmed ID: 21336113
• Eritoran Tetrasodium (E5564) Treatment for Sepsis: Review of Preclinical and Clinical Studies
  Expert Opinion on Drug Metabolism & Toxicology. Apr, 2011  |   Pubmed ID: 21323610
• The Effect of Heparin Administration in Animal Models of Sepsis: a Prospective Study in Escherichia Coli-challenged Mice and a Systematic Review and Metaregression Analysis of Published Studies
  Critical Care Medicine. May, 2011  |   Pubmed ID: 21317646
• Anthrax Edema Toxin Has CAMP-mediated Stimulatory Effects and High-dose Lethal Toxin Has Depressant Effects in an Isolated Perfused Rat Heart Model
  American Journal of Physiology. Heart and Circulatory Physiology. Mar, 2011  |   Pubmed ID: 21217068
• Anthrax Lethal and Edema Toxins Produce Different Patterns of Cardiovascular and Renal Dysfunction and Synergistically Decrease Survival in Canines
  The Journal of Infectious Diseases. Dec, 2010  |   Pubmed ID: 21067373
• SB203580, a P38 Inhibitor, Improved Cardiac Function but Worsened Lung Injury and Survival During Escherichia Coli Pneumonia in Mice
  The Journal of Trauma. Jun, 2010  |   Pubmed ID: 20068480
• Bundled Care for Septic Shock: an Analysis of Clinical Trials
  Critical Care Medicine. Feb, 2010  |   Pubmed ID: 20029343
• Risk of Death and the Efficacy of Eritoran Tetrasodium (E5564): Design Considerations for Clinical Trials of Anti-inflammatory Agents in Sepsis
  Critical Care Medicine. Jan, 2010  |   Pubmed ID: 20023474
• Bacillus Anthracis Cell Wall Produces Injurious Inflammation but Paradoxically Decreases the Lethality of Anthrax Lethal Toxin in a Rat Model
  Intensive Care Medicine. Jan, 2010  |   Pubmed ID: 19756496
• Growing Insights into the Potential Benefits and Risks of Activated Protein C Administration in Sepsis: a Review of Preclinical and Clinical Studies
  Biologics : Targets & Therapy. 2009  |   Pubmed ID: 19774207
• Can We Predict the Effects of NF-kappaB Inhibition in Sepsis? Studies with Parthenolide and Ethyl Pyruvate
  Expert Opinion on Investigational Drugs. Aug, 2009  |   Pubmed ID: 19555300
• The Heart is an Early Target of Anthrax Lethal Toxin in Mice: a Protective Role for Neuronal Nitric Oxide Synthase (nNOS)
  PLoS Pathogens. May, 2009  |   Pubmed ID: 19478875
• Antithrombosis Trials: Should We Test Therapeutic Heparin Adjusted Based on Activated Partial Thromboplastin Time in Septic Shock?
  Critical Care Medicine. Apr, 2009  |   Pubmed ID: 19318828
• Norepinephrine Increases Blood Pressure but Not Survival with Anthrax Lethal Toxin in Rats
  Critical Care Medicine. Apr, 2009  |   Pubmed ID: 19242337
• Ethyl Pyruvate Decreased Early Nuclear Factor-kappaB Levels but Worsened Survival in Lipopolysaccharide-challenged Mice
  Critical Care Medicine. Apr, 2008  |   Pubmed ID: 18176313
• Risk of Death Does Not Alter the Efficacy of Hydrocortisone Therapy in a Mouse E. Coli Pneumonia Model: Risk and Corticosteroids in Sepsis
  Intensive Care Medicine. Mar, 2008  |   Pubmed ID: 17992512
• Neuronal Nitric Oxide Synthase Deficiency Decreases Survival in Bacterial Peritonitis and Sepsis
  Intensive Care Medicine. Nov, 2007  |   Pubmed ID: 17684724
• New Insights into the Pathogenesis and Treatment of Anthrax Toxin-induced Shock
  Expert Opinion on Biological Therapy. Jun, 2007  |   Pubmed ID: 17555370
• Fluid Support Worsens Outcome and Negates the Benefit of Protective Antigen-directed Monoclonal Antibody in a Lethal Toxin-infused Rat Bacillus Anthracis Shock Model
  Critical Care Medicine. Jun, 2007  |   Pubmed ID: 17452924
• Bacillus Anthracis Edema and Lethal Toxin Have Different Hemodynamic Effects but Function Together to Worsen Shock and Outcome in a Rat Model
  The Journal of Infectious Diseases. Feb, 2007  |   Pubmed ID: 17230417
• Lethal and Edema Toxins in the Pathogenesis of Bacillus Anthracis Septic Shock: Implications for Therapy
  American Journal of Respiratory and Critical Care Medicine. Feb, 2007  |   Pubmed ID: 17095744
• DTPA Fe(III) Decreases Cytokines and Hypotension but Worsens Survival with Escherichia Coli Sepsis in Rats
  Intensive Care Medicine. Aug, 2006  |   Pubmed ID: 16775718
• Parthenolide Has Limited Effects on Nuclear Factor-kappa Beta Increases and Worsens Survival in Lipopolysaccharide-challenged C57BL/6J Mice
  Cytokine. Mar, 2006  |   Pubmed ID: 16720096
• Sublethal Doses of Bacillus Anthracis Lethal Toxin Inhibit Inflammation with Lipopolysaccharide and Escherichia Coli Challenge but Have Opposite Effects on Survival
  The Journal of Infectious Diseases. Mar, 2006  |   Pubmed ID: 16479518
• Effective Dosing of Lipid A Analogue E5564 in Rats Depends on the Timing of Treatment and the Route of Escherichia Coli Infection
  The Journal of Infectious Diseases. Mar, 2006  |   Pubmed ID: 16453258
• Antithrombotic Therapies for Sepsis: a Need for More Studies
  Critical Care Medicine. Feb, 2006  |   Pubmed ID: 16424739
• Neutrophil Stimulation with Granulocyte Colony-stimulating Factor Worsens Ventilator-induced Lung Injury and Mortality in Rats
  Anesthesiology. Nov, 2005  |   Pubmed ID: 16249674
• Reassessing Recombinant Human Activated Protein C for Sepsis: Time for a New Randomized Controlled Trial
  Critical Care Medicine. Oct, 2005  |   Pubmed ID: 16215410
• Mechanical Ventilation in ARDS: One Size Does Not Fit All
  Critical Care Medicine. May, 2005  |   Pubmed ID: 15891350
• Neutrophil Inhibition with L-selectin-directed MAb Improves or Worsens Survival Dependent on the Route but Not Severity of Infection in a Rat Sepsis Model
  Journal of Applied Physiology (Bethesda, Md. : 1985). Jun, 2005  |   Pubmed ID: 15677732
• Late Treatment with a Protective Antigen-directed Monoclonal Antibody Improves Hemodynamic Function and Survival in a Lethal Toxin-infused Rat Model of Anthrax Sepsis
  The Journal of Infectious Diseases. Feb, 2005  |   Pubmed ID: 15633102
• Recombinant Human Activated Protein C in Sepsis: Assessing Its Clinical Use
  The American Journal of the Medical Sciences. Oct, 2004  |   Pubmed ID: 15486536
• Granulocyte Colony-stimulating Factor Has Differing Effects Comparing Intravascular Versus Extravascular Models of Sepsis
  The Journal of Trauma. Sep, 2004  |   Pubmed ID: 15454812
• Severity of Sepsis Alters the Effects of Superoxide Anion Inhibition in a Rat Sepsis Model
  Journal of Applied Physiology (Bethesda, Md. : 1985). Oct, 2004  |   Pubmed ID: 15169752
• Activated Protein C in Sepsis: Emerging Insights Regarding Its Mechanism of Action and Clinical Effectiveness
  Current Opinion in Infectious Diseases. Jun, 2004  |   Pubmed ID: 15166822
• Lethality During Continuous Anthrax Lethal Toxin Infusion is Associated with Circulatory Shock but Not Inflammatory Cytokine or Nitric Oxide Release in Rats
  American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. Apr, 2004  |   Pubmed ID: 14715494
• TGF-beta1 Increases Microbial Clearance but Worsens Lung Injury During Escherichia Coli Pneumonia in Rats
  Cytokine. Nov, 2003  |   Pubmed ID: 14572790
• Protection with Antibody to Tumor Necrosis Factor Differs with Similarly Lethal Escherichia Coli Versus Staphylococcus Aureus Pneumonia in Rats
  Anesthesiology. Jul, 2003  |   Pubmed ID: 12826846
• Meta-analysis of Acute Lung Injury and Acute Respiratory Distress Syndrome Trials Testing Low Tidal Volumes
  American Journal of Respiratory and Critical Care Medicine. Dec, 2002  |   Pubmed ID: 12406836
• Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
  American Journal of Respiratory and Critical Care Medicine. Nov, 2002  |   Pubmed ID: 12403688
• Inhaled Nitric Oxide: is Systemic Host Defense at Risk?
  Critical Care Medicine. Apr, 2002  |   Pubmed ID: 11940783